SCHEMBL17023143

SCHEMBL17023143

O=C(Nc1ncc[nH]1)Oc1ccc(-c2cccc3ccccc23)c2nccnc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.44
GAA P10253 2/20 0.36
ALDH1A1 P00352 1/20 0.36
PGR P06401 1/20 0.36
PTGS1 P23219 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPT P10636 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
KDM4E B2RXH2 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ROCK2 O75116 1/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
PGGT1B P53609 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP3A5 P20815 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17023129 0.89 FGFR3 (0.46) HSP90AA1MAPTMEN1KMT2AL3MBTL1
SCHEMBL17023080 0.85 HSP90AA1 (0.38) HSP90AA1GAAMAPTMEN1KMT2A
SCHEMBL1126916 0.83 FGFR3 (0.47) MAPTMEN1KMT2AKDM4EFNTA
SCHEMBL17023018 0.82 FGFR3 (0.45) HSP90AA1GAAALDH1A1MAPTMEN1
SCHEMBL17023184 0.81 HSP90AA1 (0.38) HSP90AA1HSD17B10MAPTMEN1KMT2A
SCHEMBL17023146 0.77 ADRA2A (0.34) HSP90AA1CYP3A4FGFR3ADRA2AADRA2C
SCHEMBL17023065 0.77 FGFR3 (0.48) HSD17B10L3MBTL1KDM4EFGFR3LMNA
SCHEMBL17023037 0.73 HPGDS (0.44) HSP90AA1ALDH1A1MAPTMEN1KMT2A
SCHEMBL17023104 0.73 FGFR3 (0.53) FGFR3
SCHEMBL17023072 0.73 GAA (0.53) HSP90AA1GAAALDH1A1MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed